MY STEMS

[locksflooring]

press release
March 10, 2010, 3:04 p.m. EST · Recommend · Post:

Stem Cell Therapeutics Corp. Announces Publication of Phase IIa Stroke Data
CALGARY, ALBERTA, Mar 10, 2010 (MARKETWIRE via COMTEX) -- Stem Cell Therapeutics Corp. ("SCT" or the "Company") /quotes/comstock/11v!sss (CA:SSS 0.31, +0.04, +12.73%) wishes to announce the acceptance and publication of the paper entitled "The Beta-hCG + Erythropoietin in Acute Stroke ( BETAS) Study" by the journal "Stroke", on March 8, 2010. This paper was authored by Dr. Steven C. Cramer, from the University of California, Irvine, Dr. David Brown at Hoag Memorial Hospital Presbyterian, New Port Beach, Dr. Michael D. Hill of Foothills Hospital at the University of Calgary, and colleagues.

Dr. Allen Davidoff, VP of Product Development, commented as follows:

"The Stroke journal, published by the American Heart Association, is the top journal in the field of stroke research. Stem Cell Therapeutics is pleased to congratulate Dr. Steven C. Cramer, David Brown and Michael Hill for their efforts, acceptance and successful publication of this novel study by this highly respected, peer reviewed journal. Previously this work has only appeared in abstracts. This publication marks another important milestone in the development of NTx(R)-265 and provided the continued evidence of clinical safety and the foundation for the proof of concept study modified REGENESIS."

The BETAS study was designed as an open label trial to provide the first evidence that NTx(R)-265 could be safely administered to patients with acute ischemic stroke. A total of fifteen human subjects at three centers were administered a course of NTx(R)-265, sequential administration of human chorionic gandotropin (hCG) followed by erythropoietin (EPO), with the first dose at 24-48 hours after stroke onset. Patients were then monitored for 90 days. The study found that NTx(R)-265 appeared to be safe and patients showed improved clinical outcomes compared to published data on similar untreated stroke patients as well as a trend towards reduced infarct volumes over time in comparison to data previously described elsewhere. This preliminary examination of behavioural and motor domains highlighted priority areas that will be important to address in future studies. These results strongly support the safety of NTx(R)-265 and provide evidence for the achievability of this treatment in stroke.

About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp. is a Canadian public biotechnology company /quotes/comstock/11v!sss (CA:SSS 0.31, +0.04, +12.73%) focused on the development and commercialization of drug-based therapies to treat central nervous system diseases. SCT is a leader in the development of therapies that utilize drugs to stimulate a patient's own resident stem cells. The Company's programs aim to repair brain and nerve function lost due to disease or injury. The Company's extensive patent portfolio of owned and licensed intellectual property supports the potential expansion into future clinical programs in numerous neurological diseases such as traumatic brain injury, multiple sclerosis, Huntington's disease, Alzheimer's disease, and ALS.

These securities have not been registered under the United States Securities Act of 1933, as amended, or the securities laws of any state, and may not be offered or sold within the United States or to, or for the account or benefit of U.S. persons unless an applicable exemption from U.S. registration requirements is available.

Except for historical information, this press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risk and uncertainties, which may cause but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Contacts:
Stem Cell Therapeutics Corp.
Alan Moore, PhD
President and CEO
[phone] ext. 224
[e-mail]

Stem Cell Therapeutics Corp.
Angelika Goncalves DaSilva
Operations Manager
[phone] ext. 221
[e-mail]
www.stemcellthera.com




SOURCE: Stem Cell Therapeutics Corp.

mailto:[e-mail]
mailto:[e-mail]
http://www.stemcellthera.com


Copyright 2010 Marketwire, Inc., All rights reserved.


Most Popular
Most readMost commented 1.Mutual fund investors still wary of stocks
2.The rise and certain fall of the American Empire
3.Banks rally on M&A speculation
4.Crude oil ends up after supplies, China data
5.China's trade surplus shrinks further in February
Mutual fund investors still wary of stocks The rise and certain fall of the American Empire Banks rally on M&A speculation U.S. stocks gain as investors bid up banks Online community's uproar over Darwin's Rottweiler
Find a Broker Partner Center »
/quotes/comstock/11v!sss Stem Cell Therapeutics Corp. (SSS) /marketstate/country/CA The market is open7:46:39 pm The market is closed7:46:39 pm 0.31 Change +0.04 +12.73%
Volume 910,383 Real time quotes 0.340.320.300.280.2610a11a12p1p2p3p4p Add to portfolio ca:SSS Find a Broker Create alert /quotes/comstock/11v!sss Stem Cell Therapeutics Corp. (SSS) /marketstate/country/CA The market is open7:46:39 pm The market is closed7:46:39 pm 0.31 Change +0.04 +12.73%
Volume 910,383 Real time quotes Add to portfolio ca:SSS Find a Broker Create alert
Featured Stories
U.S. stocks gain as investors bid up banks
U.S. stocks edge higher for a second straight day thanks to a rally in the financial sector led by American...
Best Buy seeks first-mover advantage with 3D TV
Aiming to steal a beat on competitors, Best Buy's tied up with Panasonic to exclusively sell the Japanese...

Lexmark stock rebound follows moves up market

Search data reflect Yahoo concern, Microsoft gains
Yahoo may continue to lose its edge, analyst says
Yahoo Inc.’s “competitive position is weakening,” according to research published Monday by Morningstar...
More

BigCharts Virtual Stock Exchange FiLife.com WSJ Asia WSJ Europe WSJ Portuguese WSJ Spanish WSJ ChineseWSJ JapaneseWSJ RadioFinancial News
SEARCH
7:46 PM ESTMarch 10, 2010
/marketstate/country/us
New York
After/marketstate/country/uk
London
Closed/marketstate/country/jp
Tokyo
Open/marketstate/country/us
/marketstate/country/uk
/marketstate/country/jp
View All Latest News
/news/latest
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494667:44pAustralia unemployment rises to 5.3% in February

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494657:33pJapan shares rise as trading firms strengthen

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494647:31pStocks in focus for Thursday

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494637:30pHealth Minute: Urgent-Care Centers

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494627:30pBanks will find ways to replace overdraft fees

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494617:24pJapan reportedly to upgrade economic view

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494607:22pSouth Korea's Kospi rises 0.6% in early dealings

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494597:20pJapan's Q4 growth revised down to 0.9%

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494587:03pU.S. dollar buys 90.49 yen vs 90.55 late in NY

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494567:02pApril crude falls 23 cents to $81.86/bbl on Globex

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494577:02pApril gold climbs 30 cents to $1,108.40/oz on Glob

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494547:01pJapan's Nikkei up 0.6% at 10,624.74 in early trade

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494557:01pJapan's Topix Index climbs 0.6% to 928.15

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494536:59pStymied timers and gathering gold bugs

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494526:56pCORRECT: Japan's initial Q4 GDP growth was 1.1%

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494516:55pBREAKING

Japan Q4 GDP growth revised 0.9% vs initial 1.1%

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494496:53pJapan Q4 annualized growth revised to 3.8% vs 4.6%

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494476:43pAustralian shares inch up, with retailers higher

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494466:25pAfter the Bell from MarketWatch Radio Network

8c077dc4-5ad2-4f73-b9c3-a381c5fece05:1494456:23pMeasuring value of the dollar depends on view

Loading more headlines...
dow
/quotes/comstock/10w!i:dji/delayed
10,567+2.88
+0.03%nasdaq
/quotes/comstock/10y!i:comp
2,35918.27
0.78%s&p 500
/quotes/comstock/21z!i1:in\x
1,1465.17
0.45%Health Matters
12526407000001252641600000This Week in Japan
LISA TWARONITE
Fujitsu's 'antisocial' allegations
Fujitsu's disclosure incident this week shows how much Japan has changed — and also how much it remains the same./conga/kiosk/asia.html 63356
12410352000001241035200000Community
If 10 friends come over for the Super Bowl, you need $1,500 worth of 3-D glasses -- only one pair comes with the set. — NanobiojohnComment from the story:
Best Buy seeks first-mover advantage with 3-D | View comments
/conga/kiosk/community.html 63549
1252636200000
1252637100000
Health Matters

Kristen GERENCHER
Health reform needs sharper teeth
Aetna president says reform is coming, but the changes on the horizon don't go far enough.
• Hit by rate hikes, one patient fights back /conga/kiosk/health-care.html 63487 12420720000001242720000000Investment Strategies
Bankers' hour
Financials have advanced to face a significant technical test, reports Michael Ashbaugh.
• Technical Indicator: Daily premium newsletter
• Nasdaq claims key level Tuesday (sample)/conga/kiosk/investing.html 63131
12402432000001271779200000Market Junkie
A question of indexes
What's a dollar worth these days? That depends on which index you use to get the greenback's value.
• Foreigners buying fewer Treasurys?
63495
12410352000001241035200000Retirement
robert powell
Retirement boost
You need to boost your confidence in your retirement plan — and boost your savings plan.
• Top 10 places to retire | More retirement news/conga/kiosk/retirement.html 63476
12410352000001241035200000Taxes
Home sweet tax credit
The tax credit for home buyers has been extended and expanded.
• Tax tips for newlyweds
• More tax tools, tips and news/conga/kiosk/taxes.html 63489
12410352000001241035200000Video
The future is now
China and the U.S. are teaming up to make an electric car that combines technology from the two countries.
• China's BYD may build in California /conga/kiosk/video.html 63486
12518064000001251806400000British Economy
Labour of love
British Prime Minister Gordon Brown says the U.K.'s economic recovery remains fragile as his Labour Party prepares for elections.
• U.K. firms avoid 'hunted' role (First Take)/conga/kiosk/wildcard1.html 63360
12553992000001255399200000Weather
Reuters Forecast: More hurricanes
This year's storm season in the Atlantic could have several major hurricanes coming on land in the United States, meteorologists from AccuWeather warn. Hurricane season begins June 1.
/conga/kiosk/wildcard4.html 63581
MarketWatch.com Site Index
Topics
Help
Feedback
Newsroom Roster
Media Archive
Premium Products
Mobile
Podcasts
RSS
MarketWatch on Facebook
MarketWatch on Twitter
Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
License our Content

WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange
All Things Digital
MarketWatch Community
Financial News Online
WSJ.com Small Business
FiLife - Personal Finance
FINS.com - Propel your career

Copyright © 2010 MarketWatch, Inc. All rights reserved.
By using this site, you agree to the Terms of Service and Privacy Policy.
Intraday data provided by Interactive Data Real Time Services, a division of Interactive Data Corp. and subject to terms of use. Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data. More information on NASDAQ traded symbols and their current financial status. Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Dow Jones Indexes(SM) from Dow Jones & Company, Inc. SEHK intraday data is provided by Comstock and is at least 60-minutes delayed. All quotes are in local exchange time. Real-time last sale data provided by NASDAQ.